Health Care & Life Sciences » Biotechnology | Charles River Laboratories International Inc.

Charles River Laboratories International Inc. | Ownership

Companies that own Charles River Laboratories International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
5,220,717
10.87%
163,290
0.02%
06/30/2018
BlackRock Fund Advisors
3,969,919
8.27%
88,087
0.02%
06/30/2018
Fidelity (Canada) Asset Management ULC
2,931,842
6.1%
1,350,021
0.54%
06/30/2018
William Blair Investment Management LLC
1,674,688
3.49%
-36,657
0.38%
06/30/2018
AQR Capital Management LLC
1,624,387
3.38%
96,522
0.18%
06/30/2018
Renaissance Technologies LLC
1,515,300
3.16%
55,000
0.19%
06/30/2018
Ariel Investments LLC
1,317,586
2.74%
-43,691
1.64%
06/30/2018
Wells Capital Management, Inc.
1,244,205
2.59%
68,016
0.21%
06/30/2018
SSgA Funds Management, Inc.
1,203,332
2.5%
-47,333
0.01%
06/30/2018
Fidelity Management & Research Co.
1,093,838
2.27%
-55,456
0.01%
06/30/2018

About Charles River Laboratories International

View Profile
Address
251 Ballardvale Street
Wilmington Massachusetts 01887
United States
Employees -
Website http://www.criver.com
Updated 07/08/2019
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.